Keyphrases
Psoriatic Arthritis
100%
Rheumatoid Arthritis
37%
Ankylosing Spondylitis
31%
Tumour Necrosis Factor Inhibitor (TNFi)
27%
Psoriasis
23%
TNF Inhibitors
23%
Axial Spondyloarthritis (AxSpA)
23%
Denmark
20%
Knee Osteoarthritis
17%
Disease Activity
17%
Randomized Controlled Trial
14%
Arthritis Patients
13%
Placebo
13%
Risankizumab
13%
Prospective Cohort Study
12%
Comorbidity
12%
Rheumatoid Arthritis Patients
12%
Randomized Trial
12%
Spondyloarthritis
11%
Southern Sweden
11%
Population-based
11%
Population-based Cohort Study
11%
Confidence Interval
10%
Adalimumab
10%
Drug Survival
10%
Biological Treatment
10%
Sweden
9%
Biological Disease-modifying Antirheumatic Drugs (bDMARDs)
9%
Meta-analysis
9%
Osteoarthritis
9%
Weight Loss
9%
Clinical Practice
9%
Danish Population
9%
Non-radiographic Axial Spondyloarthritis
9%
Patient-reported Outcomes
8%
Gout
8%
Monotherapy
8%
Systematic Meta-analysis
8%
Inflammatory Arthritis
8%
Work Disability
8%
Inflammatory Bowel Disease
8%
Incidence Rate
8%
Observational Cohort Study
8%
Ixekizumab
8%
Biologics Register
7%
Chronic Pain
7%
C-reactive Protein
7%
National Register
7%
Pain Mechanisms
7%
Register Study
7%
Medicine and Dentistry
Psoriatic Arthritis
55%
Spondylarthritis
36%
Rheumatoid Arthritis
34%
Cohort Analysis
33%
Psoriasis
30%
Ankylosing Spondylitis
26%
Biological Product
22%
Disease
21%
Disease Activity
20%
TNF Inhibitor
20%
Rheumatology
11%
Disease Modifying Antirheumatic Drug
10%
Cohort Study
10%
Prospective Cohort Study
9%
Symptom
9%
Cross Sectional Study
9%
Patient-Reported Outcome
9%
Population
9%
Randomized Controlled Trial
9%
Gout
8%
Knee Osteoarthritis
8%
Osteoarthritis
8%
Placebo
8%
Prevalence
8%
Quality of Life
8%
Drug Therapy
8%
Gene Linkage
7%
Inflammatory Bowel Disease
7%
Rheumatic Disease
7%
Prognostic Factor
7%
Fibromyalgia
7%
C Reactive Protein
6%
Insulin Dependent Diabetes Mellitus
6%
Work Disability
6%
Tumor Necrosis Factor
5%
Odds Ratio
5%
Adalimumab
5%
Concept Mapping
5%
Systematic Review
5%
Chronic Pain
5%
Ixekizumab
5%
Logistic Regression Analysis
5%
Health Assessment Questionnaire
5%